MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$23,366K
Free Cash flow
$69,290K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from revolving line of ...
Increase in accounts receivable
Change in cash overdrafts payabl...
Others
Negative Cash Flow Breakdown
Payments on revolving line of cr...
Purchases of treasury stock
Change in current income taxes
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
67,703
66,302
76,751
64,237
Depreciation and amortization
16,986
16,873
16,330
16,234
Stock option expense
9,053
9,249
8,297
6,067
Benefit for deferred income taxes
475
-4,737
10,315
-3,016
Noncash long-term incentive compensation
2,247
1,386
1,829
-216
Noncash directors' compensation
1,191
-
0
0
Litigation settlements
548
-
-425
1,850
Amortization of debt issuance costs
83
80
80
81
Increase in accounts receivable
-26,183
32,899
-32,807
30,937
Increase in inventories
422
-335
-695
-910
Increase in prepaid expenses
10,197
88
-7,759
1,371
Increase/(decrease) in accounts payable and other current liabilities
6,939
2,235
-15,296
22,551
Change in current income taxes
-35,802
26,817
-4,055
8,602
Net change in lease assets and liabilities
-763
471
230
504
(increase)/decrease in other assets
5,886
3,603
5,213
6,378
Increase in other liabilities
4,482
6,709
4,069
4,834
Other sources
467
31
-180
445
Net cash provided by operating activities
84,813
88,219
133,533
83,389
Business combinations, net of cash acquired
12,930
20,610
0
0
Capital expenditures
15,523
17,116
16,348
17,359
Proceeds from sale of fixed assets
288
134
817
3,271
Other uses
73
197
420
146
Net cash used by investing activities
-28,238
-37,789
-15,951
-14,234
Proceeds from revolving line of credit
356,000
135,480
-
-
Payments on revolving line of credit
307,200
44,280
-
-
Purchases of treasury stock
97,482
190,039
174,556
180,776
Change in cash overdrafts payable
23,798
-493
10,360
301
Dividends paid
7,876
8,173
8,499
8,654
Proceeds from exercise of stock options
1,419
1,312
0
0
Capital stock surrendered to pay taxes on stock-based compensation
0
1,482
335
0
Debt issuance costs
1,349
-
-
-
Other (uses)/sources
-519
-414
211
-178
Net cash used by financing activities
-33,209
-108,089
-172,819
-189,307
(decrease)/increase in cash and cash equivalents
23,366
-57,659
-55,237
-120,152
Cash and cash equivalents at beginning of period
16,856
74,515
129,752
178,350
Cash and cash equivalents at end of period
40,222
16,856
74,515
129,752
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$67,703K
(-45.51%↓ Y/Y)
Increase in accounts
receivable
-$26,183K
(-294.44%↓ Y/Y)
Depreciation and
amortization
$16,986K
(-47.37%↓ Y/Y)
Stock option expense
$9,053K
(-50.55%↓ Y/Y)
Increase/(decrease) in accounts
payable and other...
$6,939K
(155.74%↑ Y/Y)
Increase in other
liabilities
$4,482K
(194.67%↑ Y/Y)
Noncash long-term
incentive compensation
$2,247K
(-31.35%↓ Y/Y)
Noncash directors'
compensation
$1,191K
(6.06%↑ Y/Y)
Net change in lease
assets and liabilities
-$763K
(-1159.72%↓ Y/Y)
Litigation settlements
$548K
Benefit for deferred
income taxes
$475K
(103.59%↑ Y/Y)
Other sources
$467K
(140.72%↑ Y/Y)
Amortization of debt issuance
costs
$83K
(-48.13%↓ Y/Y)
Net cash provided by
operating activities
$84,813K
(-50.50%↓ Y/Y)
Canceled cashflow
$52,307K
(decrease)/increase in cash and cash
equivalents
$23,366K
(-67.34%↓ Y/Y)
Canceled cashflow
$61,447K
Change in current
income taxes
-$35,802K
(-232.61%↓ Y/Y)
Increase in prepaid
expenses
$10,197K
(41.00%↑ Y/Y)
(increase)/decrease in other assets
$5,886K
(112.15%↑ Y/Y)
Increase in inventories
$422K
(-55.81%↓ Y/Y)
Proceeds from revolving
line of credit
$356,000K
Change in cash
overdrafts payable
$23,798K
(7601.62%↑ Y/Y)
Proceeds from exercise of
stock options
$1,419K
(-94.77%↓ Y/Y)
Proceeds from sale of
fixed assets
$288K
(-40.00%↓ Y/Y)
Net cash used by
financing activities
-$33,209K
(52.99%↑ Y/Y)
Net cash used by
investing activities
-$28,238K
(3.15%↑ Y/Y)
Canceled cashflow
$381,217K
Canceled cashflow
$288K
Payments on revolving
line of credit
$307,200K
Capital expenditures
$15,523K
(-46.63%↓ Y/Y)
Business combinations,
net of cash acquired
$12,930K
(5646.67%↑ Y/Y)
Purchases of treasury
stock
$97,482K
(27.98%↑ Y/Y)
Dividends paid
$7,876K
(-45.84%↓ Y/Y)
Debt issuance costs
$1,349K
Other (uses)/sources
-$519K
(-147.53%↓ Y/Y)
Other uses
$73K
(-77.33%↓ Y/Y)
Buy us a coffee
CHEMED CORP (CHE)
CHEMED CORP (CHE)